Built by operators.
Defended by intelligence.
This is the same story we tell every accredited investor — rebuilt as a live walkthrough instead of a static PDF. Scroll through the thesis, the operating platform, the portfolio, and the numbers. Then request the full data room.
Three forces just made CPG investable again.
The brands that dominated grocery shelves for fifty years — built on advertising budgets and locked-in retail relationships — are losing to founders with a phone, a community, and a product worth talking about.
TikTok destroyed the marketing moat. A $50B brand and a 2,000-case startup now reach the same consumer. The shelf is the phone — the product that wins is the one that earns attention.
AI destroyed the production-cost moat. Content that required a $500K budget now costs a few hundred dollars. UGC that took a 12-month influencer relationship is generated at scale.
The exit market has never been more active. PepsiCo paid $1.95B for Poppi. Coca-Cola paid $4.1B for Vitaminwater. Kellogg's paid $600M for RXBAR. This is the strategic playbook now, not the exception.
"We invest in brands with cult followings and underserved distribution — then build the infrastructure that turns regional love into national scale."
We turn down more brands than we back.
Every brand is measured against the same six-point filter before a dollar is committed. If it doesn't clear the bar, it doesn't get a check — regardless of how good the product tastes or looks.
| Initial Investment | $1M – $3.5M |
| Equity Stake | 20% – 35% |
| Total Ownership (A+B) | 25% – 45% |
| Board Rights | Seat or Observer |
| Founder Vesting | 3-Yr / 1-Yr Cliff |
| ESOP Pool | 10% Required |
| Affiliate Pool | 3% – 5% |
| DSD / Retail Pool | 3% – 5% (Performance) |
| Existing Incubated Pipeline | $5,000,000 · 5 Brands |
| New Deal Pipeline | $5,000,000 · 2–5 Brands |
| Follow-On Reserve | $10,000,000 · Top 2–3 Winners |
| Fund Operations | $100,000 / Year |
A $2M investment delivers $5–8M in infrastructure.
Every portfolio brand gets all 8 pillars, deployed the day capital closes — not as a consulting fee, but as the investment itself.
The castle. The moat. What capital alone can't buy.
Investors ask one question above every other: what does this fund have that a bigger check can't replicate? For most funds, the honest answer is "not much." Here is ours.
We invest in brands consumers already love — before capital arrives. You cannot buy a TikTok community that genuinely cares. You can only build it, and our brands already have.
Equity holders who create content because they own the outcome — not influencers paid per post. The difference in authenticity is categorical, not incremental.
We only invest where a credible strategic acquirer — PepsiCo, Kellogg's, L'Oréal — could plausibly buy within three years. If it takes more than one sentence to explain, the brand doesn't pass the gate.
From loading DSD trucks to advising the largest family offices in the US. Capital is abundant. This knowledge is generational — no fund at our size is catching up to it.
$900B+ in addressable market. One fund built for all of it.
Functional beverage, beauty and personal care, nutritional supplements, and live commerce — each growing faster than traditional CPG, and each inside CPG Life's operating expertise.
6 brands. Already being built with the full platform.
Hover each card for the target acquirer, exit thesis, and LatAm strategy.
| Calmara | Functional Beverage · PepsiCo, Dr Pepper KDP, Monster Energy |
| The Eye Drink | Nutraceutical Beverage · Nestlé Health Science, Reckitt, Abbott |
| The NutriSip | Functional Delivery Format · Glanbia, Abbott EAS, Dymatize |
| Forza Bar | Functional Snack · Kellogg's, Mondelēz, Mars / Kind |
| Lucky To Be Beauty | Beauty & Personal Care · L'Oréal, Unilever, Estée Lauder, Coty |
| Piancone Farms | Premium Food · Premium food and agricultural majors |
The numbers — and the exit market that backs them.
Strategic CPG acquisitions have never been more active. CPG Life Fund is designed to build exactly what conglomerates are buying.
| Fund Size | $20,000,000 |
| Structure | Delaware LP |
| Check Size | $1M – $3.5M |
| Portfolio Brands | 10 – 12 |
| Preferred Return | 8% / Year |
| Carried Interest | 20% |
| Management Fee | 2% / Year |
| Hold Period | 3 – 5 Years |
| Fund Term | 7 Years + Extensions |
| Min Investment | $250,000 |
| Investor Type | Accredited Only |
Bubble size proportional to deal value. Hover for details. Source: public company filings and press releases.
Active Buyers
PepsiCo · Coca-Cola · Dr Pepper KDP · Monster · Red Bull · Kellogg's
Exit Comps
Poppi → PepsiCo $1.95B (2025) · Siete → PepsiCo $1.2B (2024) · Bai → Dr Pepper $1.7B (2017) · Vitaminwater → Coca-Cola $4.1B (2007)
Active Buyers
L'Oréal · Unilever · Estée Lauder · Procter & Gamble · Shiseido · Coty
Exit Comps
Drunk Elephant → Shiseido $845M (2019) · Farmacy Beauty → Procter & Gamble (2021)
Active Buyers
Nestlé Health Science · Glanbia · Abbott · Reckitt · Kellogg's · Mondelēz
Exit Comps
Garden of Life → Nestlé $975M (2017) · RXBAR → Kellogg's $600M (2017) · Vital Proteins → Nestlé (2021) · Hu Kitchen → Mondelēz $340M (2021)
No finance GPs. No advisory track records. Operators only.
$20M target. $250K minimum. First close underway.
CPG Life Fund I is a Delaware LP currently accepting commitments from accredited investors. Six brands are already incubated and building with the full 8-pillar platform — the fund's proof of model before a single dollar of new LP capital is deployed on a new deal.
Request the Full Data Room
PPM, fund model, brand-level financials, and GP track record. Jorge Olson or Sandro Piancone will follow up within 48 hours.
Request Data Room →Schedule a Call
Talk directly with the GP team about allocation, timeline, and how the fund fits your portfolio.
Schedule a Call →This deck is confidential and directed solely at accredited investors. It does not constitute an offer to sell or a solicitation of an offer to buy any securities. Any decision to invest must be made solely on the basis of definitive Fund Documents. Past performance is not indicative of future results.